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ABSTRACT Toxoplasma gondii is a ubiquitous obligate intracellular parasite that in-
fects the nucleated cells of warm-blooded animals. From within the parasitophorous
vacuole in which they reside, Toxoplasma tachyzoites secrete an arsenal of effector
proteins that can reprogram host gene expression to facilitate parasite survival and
replication. Gaining a better understanding of how host gene expression is altered
upon infection is central for understanding parasite strategies for host invasion
and for developing new parasite therapies. Here, we applied ribosome proﬁling cou-
pled with mRNA measurements to concurrently study gene expression in the para-
site and in host human foreskin ﬁbroblasts. By examining the parasite transcriptome
and translatome, we identiﬁed potential upstream open reading frames that may
permit the stress-induced preferential translation of parasite mRNAs. We also deter-
mined that tachyzoites reduce host death-associated pathways and increase survival,
proliferation, and motility in both quiescent and proliferative host cell models of in-
fection. Additionally, proliferative cells alter their gene expression in ways that are
consistent with massive transcriptional rewiring, while quiescent cells were best
characterized by reentry into the cell cycle. We also identiﬁed a translational control
regimen consistent with mechanistic target of rapamycin (mTOR) activation in quies-
cent cells and, to a lesser degree, in proliferative cells. This study illustrates the util-
ity of the method for dissection of gene expression programs simultaneously in the
parasite and host.
IMPORTANCE Toxoplasma gondii is a single-celled parasite that has infected up to
one-third of the world’s population. Signiﬁcant overhauls in gene expression in both
the parasite and the host cell accompany parasite invasion, and a better under-
standing of these changes may lead to the development of new therapeutic agents.
In this study, we employed ribosome proﬁling to determine the changes that occur
at the levels of transcription and translation in both the parasite and the infected host
cell at the same time. We discovered features of Toxoplasma mRNAs that suggest a
means for controlling parasite gene expression under stressful conditions. We also show
that differences in host gene expression occur depending on whether they are conﬂu-
ent or not. Our ﬁndings demonstrate the feasibility of using ribosomal proﬁling to inter-
rogate the host-parasite dynamic under a variety of conditions.
KEYWORDS ribosomal proﬁling, Toxoplasma, apicomplexa, parasites, translation,
translation control
Toxoplasma gondii is a ubiquitous intracellular parasite that infects nucleated cells ofwarm-blooded animals. Upon infection, tachyzoites undergo a period of rapid
replication and dissemination throughout the host (1). Usually without producing
symptoms, host immunity induces the conversion of tachyzoites into latent bradyzoites
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that are contained within tissue cysts that can persist for the life of the host (2). During
immunosuppression, bradyzoites can reconvert into tachyzoites, causing severe disease
due to lysis of host cells in critical organs and tissues (3). There is currently no treatment
available to eradicate tissue cysts, and the front-line antifolate drugs that control acute
infection exhibit serious toxic effects in patients (4). A better understanding of how
intracellular tachyzoites interact with their host cells may reveal new drug targets to
treat this pathogen.
It is now well established that tachyzoites induce signiﬁcant changes inside their
host cell. An arsenal of parasite proteins is released via secretory organelles at the apical
end of the parasite upon invasion as the parasites establish the nonfusogenic parasi-
tophorous vacuole in which they reside and replicate (5). For example, the secreted
proteins ROP16, GRA6, GRA16, and GRA24 modulate transcription factor activity in the
host cell, inducing gene expression that is thought to favor parasite proliferation
(reviewed in reference 6).
In addition to initiating transcriptional changes, tachyzoites are suggested to mod-
ulate mRNA translation in the infected host cell. Toxoplasma-infected host cells show
increased mechanistic target of rapamycin (mTOR) activity and subsequent phosphor-
ylation of downstream mTOR targets (7–9). Tachyzoite-induced mTOR activation is
suggested to increase the translation of selected gene transcripts (9). Toxoplasma
infection may also activate the eukaryotic initiation factor-2 (eIF2) kinase GCN2 in
mouse embryonic ﬁbroblast (MEF) cells in response to tachyzoite consumption of host
cell arginine (10). The phosphorylation of eIF2 lowers translation initiation, which
serves to conserve nutrients and energy and enhances the translation of select mRNAs
involved in stress adaptation (11). Toxoplasma also possesses a complement of protein
kinases that phosphorylate the parasite eIF2 in response to stress and inducers of
bradyzoite development (reviewed in reference 3). Collectively, these studies suggest
that translational control mechanisms are operating in both the parasites as well as in
their host cells during infection.
Ribosome proﬁling (Ribo-seq) has emerged as a powerful method for analyzing
translational dynamics quantitatively and qualitatively (12). This technique has been
applied to protozoan parasites to improve genome annotation and to investigate
translational control in different parasite life stages or in response to chemotherapeu-
tics (13–18). In the cases of Plasmodium falciparum (the parasite that causes malaria) as
well as Toxoplasma gondii intracellular and extracellular tachyzoites, these experiments
helped identify translational control mechanisms suggested to involve upstream open
reading frames (uORFs) (13, 14).
In this study, we present a method that can be used to interrogate translational
control and transcriptome changes in intracellular parasites and their host cells simul-
taneously. Using Ribo-seq, we show that one can proﬁle intracellular tachyzoite and
host cell transcriptomes and translatomes concurrently. We utilize proliferative and
quiescent host cell models of infection to determine growth-independent changes that
occur in response to infection. We determine that gene expression changes in prolif-
erating host cells are largely driven by changes in mRNA levels. In comparison,
quiescent host cells display changes in gene expression that are controlled at the levels
of the transcriptome and translatome that are consistent with reentry into the host cell
cycle. However, bulk translational capacity, deﬁned as the relative amount of translating
ribosomes, remains largely unaltered in the infected host cell under both growth condi-
tions. We also leveraged our data sets to investigate the tachyzoite translatome for
potential uORFs, which can be regulators of transcript-speciﬁc translational control. Our
ﬁndings suggest that concurrent Ribo-seq will be a valuable tool to identify changes in both
host cells and parasites under a wide variety of experimental conditions.
RESULTS AND DISCUSSION
Concurrent host-parasite ribosome proﬁling. Conﬂuent human foreskin ﬁbro-
blast (HFF) monolayers are used routinely to study Toxoplasma infection and host-
parasite interactions in vitro, whereas subconﬂuent cells are frequently used in studies
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of stress-induced translational control in other systems. Since primary ﬁbroblasts
become quiescent upon reaching conﬂuence and subconﬂuent ﬁbroblasts are prolif-
erative (19), we reasoned that each growth condition would be a useful model for
examining the growth-dependent and -independent gene expression changes that
occur at the transcriptome and translatome levels in host cells upon tachyzoite
infection. We assessed bulk translation in conﬂuent and subconﬂuent HFFs by poly-
some proﬁling, which gauges translation by comparing the relative contribution of
polysomes and monosomes to the proﬁle (Fig. 1A and B). Conﬂuent HFFs have low
basal translation, as evidenced by a prominent monosome peak and modest polysomes
(Fig. 1A, solid lines). In comparison, proliferating subconﬂuent HFFs display larger
polysomes relative to the monosome peak, which is indicative of more robust trans-
lation (Fig. 1A, dotted lines). We quantiﬁed the proportion of RNA involved in the
polysome fraction as an indication of overall bulk translation (Fig. 1B). Indeed, trans-
lation is signiﬁcantly more robust in subconﬂuent than in conﬂuent HFFs. There were
modest, albeit statistically signiﬁcant, changes in the polysome proﬁles following 24 h
of infection with tachyzoites (Fig. 1B). These changes may be a reﬂection of altered
translational control in the host cell and/or represent a contribution of parasite RNA to
the proﬁles.
We conducted our ribosome proﬁling experiments 24 h after infection with RH strain
tachyzoites using a protocol modeled after previously published techniques (12, 13). A
schematic diagram outlining the experimental design is shown in Fig. 1C. The infected
HFF cells were treated with cycloheximide (CHX) to stop translational elongation and
then lysed in cytoplasmic lysis buffer. An aliquot of the cytoplasmic extract was
FIG 1 Polysome and ribosome proﬁling of Toxoplasma-infected HFFs. (A) Representative examples of polysome proﬁles from mock-
infected or tachyzoite-infected conﬂuent (solid lines) and subconﬂuent (dotted lines) HFFs 24 h after infection with RH strain tachyzoites
(MOI, 10). (B) Polysome abundance analysis of proﬁles performed as in panel A. The median proportions of polysomes and standard
deviation are presented for each condition. (C) Experimental design of ribosome proﬁling experiments. HFFs were infected as in panel A,
and cytoplasmic lysate was partitioned for subsequent RNA-seq and ribosome proﬁling analyses. Total RNA was fragmented by alkaline
hydrolysis. For ribosome proﬁling, cytoplasmic lysate was digested with RNase I, and monosomes were collected after centrifugation on
sucrose gradients. RFPs were collected and processed along with small RNA fragments for sequencing library preparation. (D) Example
of cytoplasmic lysate generated from infected subconﬂuent HFFs with and without digestion by RNase I. Gray dashes outline the
monosome fraction of the gradient collected for RFP isolation. *, P 0.05; **, P 0.001, one-way analysis of variance (ANOVA) with Tukey
comparison.
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collected for RNA sequencing (RNA-seq) analysis; the remainder was digested with
RNase I, followed by sucrose density centrifugation. The RNase I digests mRNA regions
that are not occupied by ribosomes, allowing for only the ribosome-protected frag-
ments, or footprints (RFPs), to be collected in the resulting monosome peak after
sucrose density centrifugation (Fig. 1D). The peak corresponding to the monosome was
collected (Fig. 1D), and the resulting RFPs were used for subsequent sequencing library
preparation (Fig. 1C). In our experiments, sucrose density centrifugation, as described
previously (13), reduced downstream rRNA contamination in our sequencing libraries
compared to the sucrose cushion method of RFP collection previously described (data
not shown, and reference 12).
We mapped our sequencing data independently to the human and Toxoplasma
ME49 strain transcriptomes. Although our experiment was conducted with the type I
strain RH, all of our analyses were mapped to the type II reference strain ME49 because
it is the most thoroughly annotated of all strains available in the ToxoDB. Metagene
proﬁles were generated for each library, and the proﬁle analyses revealed that a large
portion of the RFPs mapped to the annotated coding sequence (CDS) start codons and
progressively decreased immediately downstream in both infected human host cells
and intracellular tachyzoites (Fig. 2A and B). This “ramp-like” pattern is reminiscent of
that observed in studies detailing the effects that CHX contributes to RFP distribution
FIG 2 Enrichment of RFPs on human and Toxoplasma coding sequences. (A) Metagene plots of ribosome proﬁling data from mock-infected and
tachyzoite-infected HFFs. Transcript diagrams are labeled and drawn proportionally. Plots are generated from a representative replicate. AU, arbitrary units. (B)
Representative metagene plot as in panel A for Toxoplasma-mapping data. (C) Quantitation of ribosome proﬁling (RFP) and RNA-seq (RNA) reads that map to
each transcript feature. A computed model transcript, representing the average contribution of each feature to transcript length (expressed as a percentage
of total transcript) is shown for comparison. (D) Quantitation of RFP and RNA reads as in panel C for the sequencing reads that mapped to Toxoplasma
sequences. CON, data from conﬂuent host cell experiment; SUB, data from subconﬂuent host cell experiment.
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patterns when used as a preincubation step in Ribo-seq experiments (20–22). Our
results are consistent with the idea that CHX causes the same ramp-like perturbation to
Toxoplasma ribosome proﬁles as reported in yeast and mammalian cells and can be
leveraged to facilitate the identiﬁcation of translated uORFs in tachyzoites since it
accentuates RFP peaks near start codons.
The metagene proﬁles also revealed a consistently higher ribosome density along
the 5=-leader sequences in both host and parasite cells than in the 3=-untranslated
regions (3=-UTRs) of the transcripts (Fig. 2A and B). In analyses of the P. falciparum
translatome during the intraerythrocytic developmental cycle, an enrichment for 5=-
leader sequence representation was noted and attributed to ribosomal occupancy but
did not correlate with the presence or location of uORFs (13, 23). To determine if a
similar phenomenon occurs in Toxoplasma, we ﬁrst computed the average contribution
of each annotated feature (i.e., 5=-leader, CDS, and 3=-UTR) to coding mRNAs
transcriptome-wide using data from the Toxoplasma and human genome annotations
in EuPathDB (24) and data generated by Piovesan et al. (25). With this information, we
constructed a model for the average computed transcript in the host and parasite
(Fig. 2C and D). The average human 5=-leader composes 7.6% of the total transcript
length, whereas this feature contributes 20.9% of the total Toxoplasma mRNA length.
We then quantiﬁed the ribosome density along all coding transcripts in both host cells
and parasites, segregating them according to their feature annotation (Fig. 2C and D).
The results indicate that 8 to 10% of human RFPs and 20 to 22% of Toxoplasma RFPs
mapped to 5=-leaders, suggesting that the rate of RFP mapping to 5=-leaders in both
organisms is proportional to their length. Since the rate of RFP mapping to 5=-leaders
in both organisms appeared to be proportional to their length, and the accumulation
of RFPs within 5=-leaders has also been attributed to the CHX treatment (22), we
suggest that we are also observing CHX-induced ribosome occupancy along the
5=-leaders. Moreover, this result appears to be enhanced in Toxoplasma cells compared
to human cells due to the longer 5=-leaders in the parasite. In contrast, we saw
enrichment of RFPs mapping to CDS regions and a decreased representation of 3=-UTRs
under all conditions. Mapping of the RNA-seq data did not show a similar enrichment
(Fig. 2C and D). Approximately 80% of human and 75% of Toxoplasma RFP reads
mapped to CDS regions, and 7 to 8% of human and 2% of Toxoplasma RFPs
mapped to 3=-UTRs. The enrichment of RFPs in the CDS is expected of Ribo-seq
experiments, indicating that we have substantial data to assess translatome changes
and potential translational control in both the infected host cell and in the parasite.
Ribo-seq analysis of intracellular tachyzoites in HFF host cells. In our infected
host HFFs, 15 to 25% of the sequences mapped to Toxoplasma (Table 1), making it
possible to detect parasite-speciﬁc sequences for a survey of the tachyzoite transla-
tome. We assessed the ribosome density, a measure of translation, for all coding
transcripts that met our ﬁltering criteria, which consisted of coding genes that have
annotated 5=- and 3=-UTRs and a normalized read count of 5 in each of our biological
triplicates, as determined by DESeq2 (26). For tachyzoites grown in conﬂuent HFFs, this
TABLE 1 Ribosome proﬁling and RNA-seq library mapping statistics
Sample
% of library mapped
Conﬂuent Subconﬂuent
Human Toxoplasma Human Toxoplasma
RFP RNA RFP RNA RFP RNA RFP RNA
HFF1 63.49 86.65 —a — 63.03 80.64 — —
HFF2 53.38 87.89 — — 63.89 82.35 — —
HFF3 68.22 86.86 — — 60.44 80.76 — —
HFF-RH1 60.74 64.68 25.23 16.58 50.46 56.23 14.67 21.97
HFF-RH2 43.47 66.97 18.30 17.71 48.79 55.16 21.51 23.95
HFF-RH3 68.33 68.85 14.15 14.54 45.39 55.25 19.99 22.70
a—, samples were not infected with T. gondii.
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analysis resulted in 4,453 transcripts, whereas 5,762 transcripts met our cutoff for
tachyzoites cultured in subconﬂuent HFFs (Fig. 3A; see also Table S1A and B in the
supplemental material). Bulk ribosomal density was calculated for each transcript by
taking the quotient of normalized RFP and RNA-seq reads. There was no statistically
signiﬁcant difference between the two ribosomal density proﬁles (Student’s t test,
P 0.07), indicating that the tachyzoite translational machinery functions at a similar
capacity and throughput regardless of host cell conﬂuence (Fig. 3A).
Several reports have described the mechanisms of translational control in Toxo-
plasma, especially through the involvement of the parasite integrated stress response
(ISR) pathway (reviewed in reference 3). For example, our lab identiﬁed a subset of
transcripts that were preferentially translated in tachyzoites upon induction of endo-
plasmic reticulum (ER) stress, but the mechanism of preferential translation was not
elucidated (27). One potential mechanism could be through the usage of functional
uORFs in Toxoplasma since these cis-acting elements provide a means to achieve the
transcript-speciﬁc upregulation of stress-responsive proteins during ISR activation hy-
pothesized to be necessary for bradyzoite formation (3, 28). The in silico prediction of
uORFs is complicated by the unusually lengthy 5=-leaders of Toxoplasma transcripts (14,
29) (Fig. 2D). Consequently, longer 5=-leaders are inherently more likely to contain ORFs
upstream of the annotated CDS (14).
Ribosome proﬁling facilitates uORF discovery since it provides evidence of ribosome
occupancy along distinct ORFs. In their Ribo-seq experiment of intracellular and
FIG 3 The Toxoplasma tachyzoite translatome and potential uORFs. (A) Distribution of tachyzoite ribosome density (RD)
transcriptome-wide between parasites grown in conﬂuent or subconﬂuent HFFs for 24 h. (B) Venn diagram of transcripts
identiﬁed as encoding potential uORFs from tachyzoites grown in conﬂuent or subconﬂuent HFFs. Transcripts with at least
2-fold-greater ribosome density in their annotated 5=-leader than their annotated CDS were included in the analysis. (C)
Potential uORF in the 5=-leader of TIC20. RNA-seq data are displayed above the gene model. Ribosome proﬁling data are
positioned below the gene model, showing a peak centered over a potential uORF that encodes a 6-amino-acid peptide.
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extracellular tachyzoites, Hassan et al. reported evidence of 2,770 uORFs across the
transcriptome that generally displayed low ribosomal coverage (14). We also leveraged
our data set to discover potential uORFs in our intracellular tachyzoite samples. We
identiﬁed all coding transcripts from our data set with at least a 2-fold-higher ribosome
density on their annotated 5=-leaders than their CDS, reasoning that uORFs involved in
stress-induced translational control are often translated at the expense of their down-
stream CDS (28). This analysis yielded 226 and 147 transcripts for tachyzoites grown in
subconﬂuent and conﬂuent HFFs, respectively, with 72 transcripts present under both
culture conditions (Fig. 3B and Table S2A and B). Gene ontology analysis of these genes
did not reveal any statistically signiﬁcant enrichments in this data set. Importantly, our
Ribo-seq experiments were conducted using a mixture of HFF and intracellular
tachyzoites instead of puriﬁed parasites, and our conﬂuent HFF experiment had a lower
parasite contribution than did our subconﬂuent experiment (Table 1). Consequently,
the depth of coverage for our studies was less than that reported by Hassan et al. (14),
likely explaining the lower number of hits in our data set.
We visually inspected the ribosome proﬁles of the transcripts with high 5=-leader
ribosomal occupancy for regional spikes in RFP coverage that overlapped putative
uORFs. A potential uORF was identiﬁed in the transcript for TIC20, a member of the
apicoplast protein translocation machinery (30). The TIC20 gene was well mapped over
the entire transcript by RNA-seq, yet displayed a strong RFP peak in its 5=-leader and
very low levels of CDS translation (Fig. 3C). A small uORF encoding a hexapeptide is
overlapped by Ribo-seq reads that display a characteristic 12-nucleotide offset from the
start codon typical of ribosome footprints (12), suggesting this to be a functional uORF.
Concurrent ribosome proﬁling experiments can be designed to validate and/or screen
for potential uORFs in stressed intracellular parasites in the future. The determination
and validation of functional uORFs will likely reveal cases of transcript-speciﬁc transla-
tional control that are involved in the adaptation of Toxoplasma to stressful stimuli,
including bradyzoite induction conditions.
Proliferating and quiescent host cells respond differently to tachyzoite infec-
tion. Upon invasion, Toxoplasma tachyzoites remodel the host cell environment by
recruiting host organelles, such as the ER, Golgi apparatus, endo-lysosomes, and
mitochondria to the parasitophorous vacuole (31–33). Along with the physical reorga-
nization of the infected host cell are concomitant changes in host gene expression,
some of which are mediated directly by secreted parasite effectors originating from
rhoptries and dense-granule proteins (reviewed in reference 6). Research has also
revealed that different types of host cell backgrounds respond to Toxoplasma in
different ways (34). However, the degree to which proliferating and quiescent host cells
vary in their response to infection remains to be investigated. Therefore, we proﬁled the
transcriptomes and translatomes of conﬂuent and subconﬂuent HFFs that had been
infected (or mock-infected) with Toxoplasma for 24 h. We identiﬁed 8,461 genes that
met our inclusion criteria (detected at both the RFP and RNA levels with a normalized
mean count of 5) in conﬂuent ﬁbroblasts, of which 1,016 were differentially
expressed with a log2 fold change (FC) of 1 and met a false-discovery rate (FDR)
of 0.01 at either the RNA and/or RFP levels (Table S3A). By the same metrics, we
identiﬁed 904 differentially expressed genes among the 10,164 detectable genes in
subconﬂuent cells (Table S3B). A total of 8,427 genes were detected consistently in
all samples (Fig. 4A). We noted that most parasite-induced dysregulated expression
appeared to be equally changed at the transcriptome and translatome levels in both
conﬂuent and subconﬂuent cells. This ﬁnding suggests that these genes constitute a
core shared transcriptional response to tachyzoite infection. Gene ontology analysis
(35) of the downregulated genes suggests an enrichment (FDR, 0.05) of membrane-
resident G-protein-coupled receptors in subconﬂuent cells, whereas upregulated genes
were enriched for cytokines and transcriptional machinery (Table 2). Conﬂuent HFFs
also displayed a high enrichment suggestive of transcription factors and associated
machinery (Table 3). Highlighting the ﬁdelity of our data set, we saw changes in host
gene expression that have been reported previously, such as the parasite-induced
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FIG 4 Differentially regulated genes in HFF host cells following 24 h of tachyzoite infection. (A) Heat map of all genes identiﬁed in
ribosome proﬁling (RFP) and RNA-seq (RNA) data sets. Lanes are segregated by subconﬂuent (SUB) and conﬂuent (CON) sequencing
libraries. Data represent log2-transformed fold change upon infection. Rows are ordered from most induced (red) to most repressed
(blue). The top 10 genes from each extreme are presented. (B) Venn diagrams showing the relationship between shared and growth
condition-speciﬁc up- and downregulated genes upon infection. (C) Ingenuity Pathway Analysis of modulated cellular and molecular
functions in subconﬂuent and conﬂuent HFFs upon tachyzoite infection. Pathways with a signiﬁcance of a P value of 0.05 and that
displayed a Z score 2 in either the RFP or RNA data sets are shown. Pathways that are common between conﬂuent and subconﬂuent
HFFs are in bold.
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upregulation of CCL11, HAS3, ATF3, and EGLN3, all genes that were included as host
response factors on the ToxoGeneChip (36).
The majority of the host genes exhibiting altered expression 24 h following Toxo-
plasma infection showed differences between proliferative and quiescent HFFs (Fig. 4B).
We performed an Ingenuity Pathway Analysis (37) in order to determine which shared
and distinct molecular and cellular functions were altered upon tachyzoite infection
between conﬂuent and subconﬂuent cells (Fig. 4C). We ﬁltered our analyses to include
all pathways that met a cutoff of Z score of  2 in at least RFP or RNA data sets with
adjusted P (Padj) value of 0.05 and were not cancer-associated entries. The identiﬁed
pathways were similarly represented for both the transcriptome and translatome levels
independent of host cell conﬂuence. Tachyzoite infection signiﬁcantly repressed apo-
ptotic and necrotic death pathways, whereas there was enhanced expression of genes
TABLE 2Molecular function enrichment of gene expression changes in subconﬂuent HFFs
upon tachyzoite infection
GO term Function Padj
Upregulated
GO:0005125 Cytokine activity 6.60E04
GO:0005539 Glycosaminoglycan binding 1.98E03
GO:0008201 Heparin binding 4.55E03
GO:1901681 Sulfur compound binding 6.33E03
GO:0046873 Metal ion transmembrane transporter activity 1.14E02
GO:0000981 RNA polymerase II transcription factor activity,
sequence-speciﬁc DNA binding
1.90E02
GO:0004866 Endopeptidase inhibitor activity 4.61E02
Downregulated
GO:0004930 G-protein-coupled receptor activity 2.21E03
GO:0004871 Signal transducer activity 5.38E03
TABLE 3Molecular function enrichment of gene expression changes in conﬂuent HFFs
upon tachyzoite infection
GO term Function Padj
Upregulated
GO:0003677 DNA binding 2.26E13
GO:0046982 Protein heterodimerization activity 2.74E11
GO:0042393 Histone binding 5.18E11
GO:0097159 Organic cyclic compound binding 5.58E08
GO:1901363 Heterocyclic compound binding 5.97E08
GO:0003676 Nucleic acid binding 1.08E05
GO:0036094 Small molecule binding 5.55E05
GO:0000166 Nucleotide binding 1.07E04
GO:1901265 Nucleoside phosphate binding 1.12E04
GO:0035575 Histone demethylase activity (H4-K20 speciﬁc) 1.44E04
GO:0003688 DNA replication origin binding 4.10E04
GO:0003678 DNA helicase activity 5.19E04
GO:0005515 Protein binding 9.61E04
GO:0097367 Carbohydrate derivative binding 1.43E03
GO:0003697 Single-stranded DNA binding 3.77E03
GO:0043168 Anion binding 4.58E03
GO:0032451 Demethylase activity 4.89E03
GO:0005488 Binding 5.93E03
GO:0005200 Structural constituent of cytoskeleton 9.56E03
GO:0032405 MutLalpha complex binding 1.03E02
GO:0050501 Hyaluronan synthase activity 4.11E02
Downregulated
GO:0005539 Glycosaminoglycan binding 3.81E03
GO:0005518 Collagen binding 3.10E02
GO:0036122 BMP bindinga 3.10E02
GO:0048018 Receptor agonist activity 3.32E02
aBMP, bone morphogenetic protein.
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involved in pathways associated with cell survival, viability, and migration. These
ﬁndings are consistent with prior reports regarding the effects of tachyzoite infection
on host cells (reviewed in references 38 and 39). Of interest, an increased representa-
tion of transcription-related categories was observed speciﬁcally in the infected sub-
conﬂuent cells, underscoring the level of transcriptional reprogramming that occurs in
response to Toxoplasma. Infected conﬂuent cells displayed an increase in cell cycle-
associated pathways, suggesting that Toxoplasma infection induced these quiescent
host cells to reenter the cell cycle. Host cell cycle reentry from quiescence has been
reported by others and is characterized by an increased proportion of cells in S phase
and a block in G2/M (8, 34, 40, 41). Taken together, these results demonstrate that
quiescent and proliferating HFFs respond differently to tachyzoite infection. While both
models of infection display gene expression changes consistent with reduced death
and increased viability and motility upon infection, subconﬂuent cells predominantly
show massive transcriptional rewiring, and conﬂuent cells are best characterized by
reentry into the cell cycle.
Translational control in HFF cells infected with Toxoplasma. Recently, both the
mTOR and ISR pathways were suggested to be modulated in the host upon Toxoplasma
infection (9, 10). We used our Ribo-seq and RNA-seq data to examine the changes in
mRNA translation that occur in quiescent and proliferating HFFs at 24 h postinfection.
We compared the changes in steady-state mRNA levels to the changes in ribosome
occupancy that occur in subconﬂuent and conﬂuent HFFs harboring Toxoplasma
(Fig. 5A and B). In subconﬂuent cells, 1,204 genes met a threshold of FDR, 0.01 whereas
632 genes passed the same ﬁlter in the conﬂuent data set (Table S3A and B). The genes
in the subconﬂuent data set clearly showed ribosome occupancy changes that were
tightly correlated (R2  0.9421) with the changes in steady-state mRNA levels upon
infection (Fig. 5A), suggesting that tachyzoite-induced changes to gene expression are
driven in large part by changes in steady-state mRNA levels, likely via transcriptional
control, in proliferating cells. In contrast, the correlation between transcript levels and
ribosome occupancy in the conﬂuent data set was more widely dispersed (R2 0.8288),
most noticeably due to a subset of genes in the upper left quadrant (Fig. 5B). Encoding
mostly ribosomal proteins, these genes display modest decreases in mRNA levels while
showing increased levels of translation, indicative of translational control acting in
quiescent cells upon infection.
Although bulk translational capacity was largely unchanged in the host cells upon
infection (Fig. 1A), we analyzed the distribution of individual genes for changes in
ribosome density. A total of 102 and 43 genes (FDR, 0.05) displayed increased or
decreased ribosome density (log2 FC,1), respectively, at our 24-h postinfection time
point in conﬂuent HFFs (Fig. 5D and Table S4A). Gene ontology enrichment analysis (35)
of the translationally repressed subset did not reveal any statistically signiﬁcant (FDR,
0.05) enrichment terms associated with these genes. In contrast, the preferentially
translated genes were strongly enriched for molecular functions relating to translation
machinery, including ribosomal proteins (Fig. 5F). These transcripts are canonically
downstream targets for translational control acting through the mTOR complex 1
protein kinase (42). Increased activity of host mTOR complex 1 has been reported to
occur in as little as 2 h after Toxoplasma infection, leading to cell cycle progression,
increased bulk translation, and the preferential translation of transcripts with
5=-oligopyrimidine tracts (7–9).
We also analyzed the data set from subconﬂuent HFFs infected with Toxoplasma for
24 h to determine which host genes displayed altered translational control (Table S4B).
Applying an FDR of 0.05, only ﬁve genes were preferentially translated (log2 FC, 1),
four of which were ribosomal proteins (Fig. 5C and E). In addition, although they did not
meet our 2-fold change cutoff, many other ribosomal proteins trended toward prefer-
ential translation in infected subconﬂuent HFFs (Table S4B). These results are consistent
with a modest mTOR-like activation by Toxoplasma which may be muted due to the
strong basal mTOR activity in proliferating HFFs. There were no translationally re-
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pressed transcripts observed in the subconﬂuent data set (Fig. 5C), suggesting that
Toxoplasma does not induce a signiﬁcant ISR in proliferating HFFs. Alternatively,
Toxoplasma may induce an ISR earlier during infection in subconﬂuent HFFs that is
resolved by the 24-h time point. For example, in MEF cells, GCN2 was reported to be
activated as early as 2 h postinfection with Toxoplasma (10). The simultaneous Ribo-seq
method reported here will serve as an invaluable tool to clarify host-parasite interac-
tions in multiple cell types over the time course of infection.
FIG 5 mTOR-coordinated translational control in HFFs at 24 h postinfection. (A and B) Scatterplots of log2 fold changes of mRNA
steady-state (RNA) and ribosome footprint (RFP) libraries for subconﬂuent (A) and conﬂuent (B) HFFs 24 h postinfection. Colored genes
are called by DESeq2 with an adjusted P value (Benjamini-Hochberg method) that meets a false-discovery rate of 0.01. Red dots
represent genes that change in mRNA and RFP abundance, yellow dots represent genes that change in mRNA abundance only, and
blue dots represent genes that change in RFP abundance only. (C and D) Scatterplot of log2-transformed fold change to ribosome
density upon infection in subconﬂuent (C) and conﬂuent (D) HFFs as a function of –log10-transformed Padj value. Signiﬁcantly (FDR,
0.05) preferentially translated genes are in red, while signiﬁcantly translationally repressed genes are in blue. (E and F) Gene ontology
enrichment analysis of molecular functions associated with genes displaying increased ribosome density upon infection in subcon-
ﬂuent (E) and conﬂuent (F) HFFs.
Ribo-Seq of Toxoplasma-Infected Host Cells
May/June 2019 Volume 4 Issue 3 e00292-19 msphere.asm.org 11
Conclusions. Our study demonstrates the feasibility of concurrently proﬁling host
and parasite translation during infection using either proliferative or quiescent host cell
models of infection. At 24 h postinfection, we achieved nearly 25% representation of
the Toxoplasma translatome, which was sufﬁcient to allow identiﬁcation of candidate
uORFs for further interrogation. In addition, our results show that bulk translational
capacity in tachyzoites remains unchanged in conﬂuent or subconﬂuent host cells. We
also demonstrated that both conﬂuent and subconﬂuent HFFs exhibit gene expression
patterns that are consistent with decreased cell death, increased survival, and cell cycle
progression of previously quiescent cells. These gene expression patterns are consis-
tent with prior observations of Toxoplasma-infected cells (8, 34, 38–41). Finally, our
results revealed changes in translational control that are consistent with mTOR activa-
tion both in quiescent and, to a lesser extent, in proliferating HFFs. The ability to
perform simultaneous ribosome proﬁling of intracellular pathogens within their host
cells offers a new means to investigate host-parasite translational control in a wide
variety of other host cell types and culture conditions, further illuminating mechanisms
underlying infection, drug activity, or development into latent bradyzoites in HFFs or
other host cell backgrounds.
MATERIALS AND METHODS
Host cell and parasite culture. Human foreskin ﬁbroblasts (ATCC SCRC-1041) were cultured in
Dulbecco’s modiﬁed Eagle medium (DMEM; Corning) supplemented with 10% fetal bovine serum (FBS;
Atlanta Biologicals) without antibiotic/antimycotic. After reaching conﬂuence, the monolayer was rinsed
brieﬂy with phosphate-buffered saline (PBS), resuspended in trypsin, quenched with host cell medium,
and passed into fresh ﬂasks. Routine passage of Toxoplasma gondii strain RH (ATCC 50174) was
conducted as previously described (43). Brieﬂy, conﬂuent HFF monolayers were switched to DMEM
supplemented with 1% FBS without antibiotic/antimycotic and infected with parasites.
For all experiments using conﬂuent host cells, HFF monolayers were allowed to reach conﬂuence for
1 week prior to infection. Subconﬂuent HFFs were generated by subculturing host cells as described
above 24 h prior to infection. At this stage, cells were 60% conﬂuent. All experiments were conducted
on host cells that were between passages 7 and 11. Infection of HFFs was conducted using freshly lysed
parasites that were centrifuged at 3,400 g for 5 min and resuspended in fresh host cell medium (e.g.,
with 10% FBS). Infection of conﬂuent or subconﬂuent HFFs (multiplicity of infection [MOI], 10) was
conducted by adding prepared parasites to ﬂasks without changing the medium. Mock infection was
conducted by adding the same volume of fresh medium to uninfected ﬂasks (200 l of fresh medium in
30 ml of preexisting medium). Parasites were incubated with host cells for 24 h prior to sample collection
for polysome or ribosome proﬁling.
Polysome proﬁling. Polysome proﬁling was conducted as previously described (44). Brieﬂy, cultured
cells were incubated in 50 g/ml cycloheximide (CHX) for 10 min and then washed in PBS containing
CHX. The samples were lysed in cytoplasmic lysis buffer solution (20 mM Tris [pH 7.4], 100 mM NaCl,
10 mMMgCl2, 0.4% Nonidet P-40, 50 g/ml CHX), clariﬁed by centrifugation at 12,000 g for 10 min, and
applied to a 10 to 50% sucrose gradient made in cytoplasmic lysis buffer without detergent. Gradients
were subjected to centrifugation at 200,000 g for 2 h at 4°C in a Beckman SW-41 Ti rotor. Polysome
proﬁles were generated by applying the gradients to a Piston Gradient Fractionator (BioComp, Canada)
and continuously reading the eluate at 254 nm with an EconoUV monitor (Bio-Rad, USA) paired with
WinDaq software (DataQ Instruments, USA). Polysomes were measured by calculating the area under the
curve between the disome to the end of the polysomal region (outlined in Fig. 1D) and dividing by the
total absorbance proﬁles.
Ribosome proﬁling. Samples for ribosome proﬁling were generated as outlined in reference 12.
Cytoplasmic extracts were generated as for polysome proﬁling, with a few modiﬁcations: detergent was
exchanged for 1% Triton X-100, and the buffer was supplemented with 25 units/ml of Turbo DNase I
(Invitrogen). An aliquot of cytoplasmic lysate was immediately stored in TRIzol LS reagent (Ambion) for
the extraction of total RNA. The bulk of cytoplasmic lysate was incubated with 100 units of RNase I
(Ambion) at 4°C for 1 h while rotating. The amount of RNase I was empirically determined to optimize
RFP generation by analyzing the polysome proﬁles of digested samples (Fig. 1D, and data not shown).
Sample digestion was quenched by the addition of 200 units of SUPERase·IN (Ambion). Digested samples
were run on 10 to 50% sucrose gradients prepared as for polysome proﬁling with the addition of
SUPERase·IN. The fractions corresponding to the monosome peak of centrifuged samples were collected
using the same setup for polysome proﬁling paired with a Gilson fraction collector. RFPs and total RNA
samples were collected from the TRIzol reagent. Total RNA was fragmented by alkaline hydrolysis. RFPs
and fragmented RNA were collected by gel extraction from a 15% denaturing NuPAGE gel (Invitrogen).
The TruSeq Ribo Proﬁle kit was used, as per the manufacturer’s instructions, to generate sequencing
libraries for the conﬂuent data set. The subconﬂuent sequencing libraries were generated as previously
described (12). rRNA depletion was performed using the Ribo-Zero kit (Illumina) for all libraries with the
modiﬁcations prescribed by McGlincy and Ingolia (12). Single-end 75-bp reads were generated on a
NextSeq system (Illumina).
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Sequencing data analysis. Annotated genomes and transcriptomes were downloaded from HostDB
(https://hostdb.org/hostdb/) and ToxoDB (https://toxodb.org/toxo/) (v37) (24). Libraries were depleted of
reads aligning to human or Toxoplasma rRNA in silico using the Bowtie algorithm (v0.1.0) (45), as
implemented through the RiboGalaxy interface (46). Adapter sequences were removed from unaligned
reads using the Clip function in the FastX-Toolkit, as implemented through the public Galaxy server (47).
Metagene plots were generated by aligning the libraries to the human or Toxoplasma transcriptomes
with Bowtie (45) and following the RiboSeqR pipeline (v1.0.5) (48), as implemented through the
RiboGalaxy platform (46). All further analysis was conducted utilizing the publicly assessable Galaxy
server (47).
Differential gene expression, ribosomal density, and identiﬁcation of translational controlled genes
were conducted by ﬁrst aligning the libraries to the human and Toxoplasma genomes with HISAT2
(v2.1.0) (49). Feature counts were obtained using the htseq-count algorithm (0.9.1) (50) using the -union
option. Differential expression analysis was conducted with DESeq2 (v2.11.40.2) (26). Ribosomal density
was determined by taking the quotient of RFPs and RNA-seq normalized read counts obtained via
DESeq2. Only genes that were detected at the transcriptome and translatome levels with a normalized
read count of 5 were included for these analyses. The identiﬁcation of translationally controlled gene
expression was performed by assessing changes in ribosome density between infected and mock-
infected conditions using Riborex (51).
The ribosome density across each coding gene was calculated by determining the proportion of
nonoverlapping reads that segregated to 5=-UTR, CDS, or 3=-UTR feature annotations with the htseq-
count algorithm (50), using the -intersection (strict) option. Only genes that had annotated 5=-UTRs,
3=-UTRs, and CDS were included in the analysis. The total number of reads allocated to each feature was
calculated with the formula no. of 5= reads/(no. of 5= reads  no. of CDS reads  no. of 3= reads). Genes
that harbored potential uORFs were identiﬁed by determining those that had 2-fold-higher RFP reads in
their annotated 5=-UTR compared to their CDS, with a minimum read count of at least 10 in both features.
Gene and pathway enrichment analyses. Gene enrichment analysis of upregulated and down-
regulated genes as well as for preferentially translated or translationally repressed transcripts was
performed with the goseq algorithm (v1.26.0) (35), as implemented through the publicly assessable
Galaxy server (47). The reported results were reduced in complexity using the Revigo Web server (52) and
are limited to molecular functions that meet an FDR of 0.05.
Pathway enrichment analysis was performed using Ingenuity Pathway Analysis (37) (Qiagen). The
analysis was restricted to those genes that met a normalized read count of 5, a log2 FC of 1, and
a Padj value of 0.01 as determined by DESeq2. The reported results are limited to the molecular and
cellular functions that were not annotated as pertaining to cancer or tumors and were disrupted by a Z
score of 2 with an associated Padj value of 0.05.
Data availability. All data sets from this work have been made available in the NCBI GEO database
(accession no. GSE129869).
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